Global Plasma Therapy Market Size to Reach $653.5 Billion at a CAGR of 13.9% by 2030

The Global Plasma Therapy Market size reached USD 359.8 Billion in 2022. Vantage Market Research expects the market to reach USD 653.5 Billion by 2030, exhibiting a growth rate (CAGR) of 13.9% during 2023-2030.

Table of Content [TOC]

Revitalizing Health: Exploring the Potential and Progress of Plasma Therapy

Introduction to Plasma Therapy

Plasma is the clear liquid portion of the blood that contains essential proteins, antibodies, and other nutrients. Blood plasma has always been a vital component of the healthcare industry due to its versatility and therapeutic benefits. Plasma Therapy or plasmapheresis is a medical procedure involving plasma extraction from the blood to treat various medical conditions such as autoimmune disorders, Kawasaki disease, and hemophilia.

Request Sample Report of Plasma Therapy Market @ https://www.vantagemarketresearch.com/plasma-therapy-market-2256/request-sample

Top Companies in Global Plasma Therapy Market

• Cambryn Biologics LLC (U.S.)
• BioLife Plasma Services (U.S.)
• CSL Ltd. (Australia)
• Biotest Pharmaceuticals (Germany)
• Kedrion S.P.A. (Italy)
• Grifols International S.A. (Spain)
• China Biologic Products Inc. (China)
• LFB Plasma (U.S.)

Plasma is the liquid part of the blood that carries vital nutrients, hormones, and proteins, including antibodies. When a person contracts an infection, their immune system produces a variety of antibodies to fight the disease. These antibodies remain present in the plasma even after the patient recovers, and here lies the concept of Plasma Therapy. By extracting this plasma and infusing it into the bloodstream of patients who are still fighting the disease, doctors can transfer these antibodies to the patient’s bloodstream. The antibodies produced by the recovered patient's immune system can help the recipient's immune system fight the disease.

The COVID-19 effect on Plasma Therapy

COVID-19 is a new virus, and there are no vaccines or effective treatments available till now. While several clinical trials are underway to develop these, many patients cannot wait for so long as their life is at stake. Amid this chaos, Plasma Therapy has emerged as a promising treatment option for COVID-19. Several breakthroughs have been registered in the past. In April 2020, the US FDA issued an emergency authorization to use Plasma Therapy for COVID-19 on a case-by-case basis. In August, India also approved its usage for treating critically ill patients. Several countries worldwide are now using this therapy to treat COVID-19 patients, and the results have been encouraging.

History of Plasma Therapy

Plasma Therapy has been used for over a century, primarily for treating infections. In the early 1900s, doctors used the plasma of individuals who had recovered from infectious diseases such as measles and scarlet fever to prevent the spread of these diseases. Plasma Therapy gained attention during the Spanish Flu pandemic in 1918 when doctors used plasma from recovered patients to treat those still infected. During World War II, Plasma Therapy was used to treat wounded soldiers, and in the 1950s, it started being used for treating coagulation problems.

The Science of Plasma Therapy

Plasma Therapy utilizes the healing properties of blood plasma, including antibodies, proteins, and enzymes. Large quantities of plasma are extracted from a healthy donor and given to the patient via an intravenous drip. The donor plasma is screened carefully to prevent the transmission of any infectious diseases, and the patient’s response to the therapy is monitored closely.

Buy Now Our Plasma Therapy Industry Report @ https://www.vantagemarketresearch.com/buy-now/plasma-therapy-market-2256/0

The Popularity of Plasma Therapy

Plasma Therapy has become more popular in recent years due to the advent of new technologies that produce more quantities of plasma. Additionally, Plasma Therapy has shown promising results in treating COVID-19 patients. Infusions of plasma from recovered COVID-19 patients help to boost the immune system of patients and help combat the virus. Plasma Therapy has also successfully treated autoimmune disorders like multiple sclerosis and rheumatoid arthritis.

Challenges in Plasma Therapy Market

The high cost of Plasma Therapy treatment is a significant challenge in the market, making it difficult for patients to afford it. Plasma Therapy treatments can also be affected by various factors, such as sourcing issues and regulatory policies. Additionally, the increasing competition among players in the market is creating a challenging environment, and companies need to innovate continually to stay competitive.

Future of Plasma Therapy

The increasing demand for Plasma Therapy treatments for various diseases and the advancements in technology to produce more plasma have created enormous growth opportunities for the market. Researchers are also exploring the use of Plasma Therapy in treating Alzheimer’s and Parkinson’s disease. Moreover, Plasma Therapy has a promising role in the development of vaccines and could be a game-changer in future vaccine production.

Conclusion

Plasma Therapy has become a vital part of modern medicine, and its versatility has been recognized in treating various diseases. Although the market still faces challenges, the increasing prevalence of chronic diseases and the growing demand for efficient treatment options will continue to drive the growth of the Plasma Therapy market. With continuous innovation and advancements in technology, Plasma Therapy has the potential to revolutionize the healthcare industry.

Read Our Latest Press Release:  Healthcare Facilities Management Market - In-depth Analysis

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: [email protected]

Website: Vantage Market Research